InGeNA Submission on the Ban of Genetic Discrimination The Industry Genomics Network Alliance (InGeNA) has made a submission to the Treasury Laws Amendment (Genetic Discrimination) Bill 2025 consultation, representing the collective voice of Australia’s genomics and...
Every patient responds differently to medication. For some, a standard dose offers relief; for others, the same medication may cause adverse effects or offer no benefit at all. Pharmacogenomics – an essential pillar of precision medicine – aims to change this by...
Precision medicine, also referred to as personalised medicine, represents a transformative approach in healthcare, tailoring medical treatment to the individual characteristics of each patient. Central to this paradigm is genomics – the comprehensive study of an...
